Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B.

@article{Dai2017HepaticEO,
  title={Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B.},
  author={Erhei Dai and Lianshan Zhang and Lihong Ye and Shiqing Wan and Lulu Feng and Qi Qi and Fang Yao and Zhen Li},
  journal={International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
  year={2017},
  volume={59},
  pages={
          124-130
        }
}
BACKGROUND The endocannabinoid system is involved in the pathogenesis of liver fibrosis. However, most of the findings in this area have come from experimental studies in animal models or clinical trials on chronic hepatitis C. The roles of cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) in hepatofibrosis in patients with chronic hepatitis B (CHB) have not been studied fully. This study aimed to explore the relationship between liver fibrosis and the expression of CB1 and CB2 in… CONTINUE READING
1
Twitter Mention